Comprehensive therapy for retinal artery occlusion

Authors: Li Yifeng,  Wei Wenbin

DOI: 10.3760/cma.j.issn.2095-0160.2017.01.020
Published 2017-01-10
Cite as Chin J Exp Ophthalmol, 2017,35(1): 93-96.

Abstract

Retinal artery occlusion (RAO) is an ocular emergency.Inappropriate therapy results in visual loss.Visual loss caused by RAO occurs as a result of loss of blood supply with the inner retinal layers.We reviewed a number of therapies that have been used in the treatment of RAO, including vasodilators, reducing intraocular pressure, neuro regulation, ocular fundus laser, surgery, etc.Thrombolytic therapy may result in an increased risk of intracranial and systemic hemorrhage, while the intravenous use of thrombolytic therapy should be within a window of time.At the same time, it is noticed that patients with RAO may have a risk of cerebral stroke and other vascular conditions.The risk factors for RAO are same as to atherosclerotic risk factors in stroke and heart disease, and these tactors must be actively evaluated to prevent further medical comorbidities.

Key words:

Retinal artery occlusion; Treatment; Thrombolytic; Stroke

Contributor Information

Li Yifeng
Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
Wei Wenbin
(Read 208 times, 3 visits today)
Updated: September 4, 2019 — 11:24 am